Filing Details
- Accession Number:
- 0000950103-17-003049
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-03-31 17:11:03
- Reporting Period:
- 2017-03-29
- Filing Date:
- 2017-03-31
- Accepted Time:
- 2017-03-31 17:11:03
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 744825 | American Shared Hospital Services | AMS | Services-Medical Laboratories (8071) | 942918118 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 946042 | A Ernest Bates | Two Embarcadero Center, Suite 410 San Francisco CA 94111 | Chairman And Ceo | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2017-03-29 | 5,000 | $4.24 | 650,147 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2017-03-30 | 5,000 | $4.21 | 645,147 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- This is the weighted average sale price. Shares were sold in multiple transactions at prices from $4.20 to $4.35. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4.
- This is the weighted average sale price. Shares were sold in multiple transactions at prices from $4.20 to $4.25. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4.
Billionaire Hedge Funds
